| Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: a randomized controlled trial LC Clark, GF Combs, BW Turnbull, EH Slate, DK Chalker, J Chow, ... Jama 276 (24), 1957-1963, 1996 | 3591 | 1996 |
| The empirical distribution function with arbitrarily grouped, censored and truncated data BW Turnbull Journal of the Royal Statistical Society: Series B (Methodological) 38 (3 …, 1976 | 2081 | 1976 |
| Group sequential methods with applications to clinical trials C Jennison, BW Turnbull CRC Press, 1999 | 1686 | 1999 |
| The national lung screening trial: overview and study design National Lung Screening Trial Research Team Radiology 258 (1), 243-253, 2011 | 943 | 2011 |
| Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. LC Clark, B Dalkin, A Krongrad, GF Combs Jr, BW Turnbull, EH Slate, ... British journal of urology 81 (5), 730-734, 1998 | 863 | 1998 |
| Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer … AJ Duffield-Lillico, ME Reid, BW Turnbull, GF Combs, EH Slate, ... Cancer Epidemiology and Prevention Biomarkers 11 (7), 630-639, 2002 | 640 | 2002 |
| Nonparametric estimation of a survivorship function with doubly censored data BW Turnbull Journal of the American statistical association 69 (345), 169-173, 1974 | 592 | 1974 |
| Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer … AJ Duffield‐Lillico, BL Dalkin, ME Reid, BW Turnbull, EH Slate, ET Jacobs, ... BJU international 91 (7), 608-612, 2003 | 572 | 2003 |
| Monitoring for clusters of disease: application to leukemia incidence in upstate New York BW Turnbull, EJ Iwano, WS Burnett, HL Howe, LC Clark American Journal of Epidemiology 132 (supp1), 136-143, 1990 | 362 | 1990 |
| Nonparametric and semiparametric estimation of the receiver operating characteristic curve F Hsieh, BW Turnbull Annals of statistics 24 (1), 25-40, 1996 | 359 | 1996 |
| Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial AJ Duffield-Lillico, EH Slate, ME Reid, BW Turnbull, PA Wilkins, ... Journal of the National Cancer Institute 95 (19), 1477-1481, 2003 | 319 | 2003 |
| Interim analyses: the repeated confidence interval approach C Jennison, BW Turnbull Journal of the Royal Statistical Society: Series B (Methodological) 51 (3 …, 1989 | 282 | 1989 |
| An analysis of cancer prevention by selenium GF Combs Jr, LC Clark, BW Turnbull Biofactors 14 (1‐4), 153-159, 2001 | 279 | 2001 |
| Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial ME Reid, AJ Duffield-Lillico, L Garland, BW Turnbull, LC Clark, ... Cancer Epidemiology and Prevention Biomarkers 11 (11), 1285-1291, 2002 | 245 | 2002 |
| Latent class models for joint analysis of longitudinal biomarker and event process data: application to longitudinal prostate-specific antigen readings and prostate cancer H Lin, BW Turnbull, CE McCulloch, EH Slate Journal of the American Statistical Association 97 (457), 53-65, 2002 | 213 | 2002 |
| Statistical approaches to interim monitoring of medical trials: a review and commentary C Jennison, BW Turnbull Statistical Science 5 (3), 299-317, 1990 | 205 | 1990 |
| Repeated confidence intervals for group sequential clinical trials C Jennison, BW Turnbull Controlled Clinical Trials 5 (1), 33-45, 1984 | 183 | 1984 |
| Mid‐course sample size modification in clinical trials based on the observed treatment effect C Jennison, BW Turnbull Statistics in Medicine 22 (6), 971-993, 2003 | 181 | 2003 |
| Reduction of cancer risk with an oral supplement of selenium. GF Combs Jr, LC Clark, BW Turnbull Biomedical and environmental sciences: BES 10 (2-3), 227-234, 1997 | 162 | 1997 |
| Group sequential tests for bivariate response: Interim analyses of clinical trials with both efficacy and safety endpoints C Jennison, BW Turnbull Biometrics, 741-752, 1993 | 162 | 1993 |
